Please FOLLOW this format/outline for your case analysis:
A) Identification of the Problem, Main Issue, OR Learning Point of the Case
B) Situation Analysis
C) Recommendations and/or Conclusions
Note: Turning in your answer using a Q&A format will NOT earn any credit points.
1) As CEO of a leading pharmaceutical firm, how do you respond to Dr. Margaret Chan’s (Director-General of the WHO) statements that the pharmaceutical industry is primarily “profit-driven” and had failed to invest in the development of a vaccine or cure for Ebola?
2) You are a shareholder of a pharmaceutical firm that announced its new investment to develop an Ebola vaccine and that as a result, your dividend would be reduced, would you support or not support the firm’s decision to spend your money to combat Ebola? Explain your answer.
3) Take the role of a US government official. What would be your recommendations to incentivize pharmaceutical firms to develop an Ebola vaccine?